Aurora kinase A (AURKA) is an important mitotic kinase involved in the G2/M transition, centrosome maturation and separation, and spindle formation in somatic cells. We used transgenic models that specifically overexpress in mouse oocytes either wild-type (WT-AURKA) or a catalytically inactive (kinasedead) (KD-AURKA) AURKA to gain new insights regarding the role of AURKA during oocyte maturation. AURKA activation occurs shortly after hCG administration that initiates maturation in vivo. Although AURKA activity is increased in WT-AURKA oocytes, resumption of meiosis is not observed in the absence of hCG administration. Control oocytes contain one to three microtubule organizing centers (MTOCs; centrosome equivalent) at prophase I. At the time of germinal vesicle breakdown (GVBD), the first visible marker of resumption of meiosis, the MTOC number increases. In WT-AURKA oocytes, the increase in MTOC number occurs prematurely but transiently without GVBD, whereas the increase in MTOC number does not occur in control and KD-AURKA oocytes. AURKA activation is biphasic with the initial activation not requiring CDC25B-CDK1 activity, whereas full activation, which is essential for the increase in MTOCs number, depends on CDK1 activity. AURKA activity also influences spindle length and regulates, independent of its protein kinase activity, the amount of MTOC associated with gamma-tubulin. Both WT-AURKA and KD-AURKA transgenic mice have normal fertility during first 6 mo of life. These results suggest that although AURKA is not a trigger kinase for G2/M transition in mouse oocytes, it regulates MTOC number and spindle length, and, independent of its protein kinase activity, gamma-tubulin recruitment to MTOCs.
INTRODUCTION
The members of the Aurora family of serine/threonine kinase (Aurora kinase A, B, and C) have emerged as crucial regulators of mitosis and meiosis. Although these kinases share sequence homology in their central catalytic domains, they have distinct localizations and functions. Aurora kinase A (AURKA) is a key mitotic protein kinase that associates with centrosomes [1] and the spindle [2] , and drives centrosome maturation, separation, and spindle formation [1, [3] [4] [5] [6] [7] . AURKA facilitates mitotic entry by recruiting cyclin B (CCNB) to the centrosome [4] and by phosphorylating CDC25B [8, 9] . AURKA is also responsible for the initial activation of Polo-like kinase (PLK1) before mitotic entry by phosphorylating T210 [10, 11] . AURKA was initially proposed to be upstream of CDK1 activation during mitotic entry because RNA interference (RNAi)-mediated AURKA knockdown in synchronized HeLa cells prevents CDK1 activation and mitotic entry [4] . Other works demonstrated, however, that inhibition of AURKA causes only a delay in mitotic entry during a normal cell cycle for both cancerous and nontransformed mammalian cells [6, 12, 13] . AURKA activity is essential for G2 checkpoint recovery following DNA-damage induced G2 arrest [10, 14, 15] .
In mouse oocytes, AURKA localizes to microtubule organizing centers (MTOCs) at the germinal vesicle (GV) stage, to proximal microtubules (MTs) in metaphase I, and to the midbody during telophase I [16, 17] . We previously demonstrated that RNAi-mediated reduction of AURKA during in vitro meiotic maturation results in a small but significant delay in resumption of meiosis [16] , a finding consistent with the AURKA inhibitor MLN8054 eliciting a delay in resumption of meiosis [18] . Moreover, RNAimediated knockdown of AURKA results in mouse oocytes arrested in metaphase I with disorganized spindles [16] . These findings are consistent with TPX2, a known activator of AURKA [19, 20] , control of meiotic spindle formation by regulating TACC3 phosphorylation on MTOCs [21] . In addition, microinjection of a constitutively active AURKA into Xenopus oocytes induces hormone-independent resumption of meiosis [22] and overexpression of a mutant form of AURKA, in which inhibitory phosphorylation sites Ser-283 and Ser-284 are replaced by Ala residues, accelerates resumption of meiosis in porcine oocytes cultured in vitro by increasing CCNB accumulation [23] .
AURKB is a critical component of the chromosome passenger complex, which also contains INCENP, Survivin, and Borealin, and is required for correct MT attachment to kinetochores, a robust spindle assembly checkpoint (SAC), and for cytokinesis [15] . Moreover, vertebrates also have AURKC, which is highly similar to AURKB and whose expression is restricted to the germ line and some types of cancerous cells [24] [25] [26] , where it competes with AURKB for binding to INCENP [27] . In mouse oocytes meiosis I, both AURKB and AURKC localize to the centromeric region, but AURKC also is found along the chromosome arms [28] . In metaphase II, only AURKC localizes to the centromere, and AURKB expression is very low without a clear localized signal [28] . Pharmacological inhibition of AURKB and AURKC results in abnormal chromosome congression, attenuation of the SAC activity, and cytokinesis defects. Although securin is destroyed in anaphase and homologous chromosomes separate in meiosis I following overexpression of AURKC, overexpression of AURKB blocks proper anaphase-promoting complex/cyclosome activation and securin destruction [28] . The results of recent experiments find that female mice lacking AURKC are subfertile partly as a result of chromosome misalignment that leads to MI arrest and that AURKB protein is less stable than AURKC during meiotic maturation [29] .
Mammalian oocytes removed from their follicle spontaneously resume meiosis when placed in a suitable culture medium, and maturation is inhibited by maintaining elevated concentrations of cAMP using PDE inhibitors [30] [31] [32] . Resumption of meiosis in vivo, however, is induced by luteinizing hormone (LH) binding to LH receptors located mainly on mural granulosa cells. Activation of the LH receptor, via an EGF-like signaling pathway, ultimately results in a decreased flow of cGMP from cumulus cells to the oocyte, thereby relieving cGMP-mediated inhibition of oocyte PDE3A [33] . Thus, mechanisms that promote the maturation-associated decrease in oocyte cAMP could, in principle, differ in vitro and in vivo, and in particular with respect to upstream regulators of CDK1 such as CDC25B and WEE1B [34] [35] [36] . For example, WEE1B activity, which inhibits CDK1 activity, is inhibited following AURKA-PLK1-mediated phosphorylation [37, 38] whereas CDC25B, which activates CDK1 activity, is activated by AURKA-mediated phosphorylation [8, 9] ; AURKA is activated prior to germinal vesicle breakdown (GVBD) [16] .
We previously examined the effect of overexpressing AURKA on mouse oocyte maturation in vitro with particular attention focused on its ability to activate CDK1 and MTOCs [16] . Because of potential differences between in vitro and in vivo regulation of oocyte maturation, we employed two in vivo models: the first expresses wild-type AURKA (WT-AURKA) and a second expresses a catalytically inactive, that is, kinase dead, AURKA (KD-AURKA) to establish kinase-dependent and -independent functions during meiotic maturation. In addition, we investigated the relationship between AURKA and CDC25B-CDK1 activity in vivo using Cdc25b À/À oocytes. Consistent with our previous findings [16] , we find that AURKA in vivo is essential for proper spindle formation during meiosis I and regulates MTOC number. We extend these findings using our in vivo model by demonstrating that (1) AURKA is not a trigger kinase for resumption of meiosis in vivo; (2) although AURKA activation occurs very early during resumption of meiosis, full activation of AURKA depends on CDC25B-CDK1; (3) an increase in MTOC number occurs in vivo after GVBD and can be uncoupled from GVBD by premature AURKA activation; (4) the increase in MTOC number (parallel to centrosome separation) depends on CDC25B-CDK1 signaling, which differs from what occurs during mitosis and centrosome separation; and (5) AURKA influences MTOC associated c-tubulin independent of its kinase activity.
MATERIALS AND METHODS

Generation of Aurka Transgenic and Cdc25b
À/À Mice and Their Genotyping
To generate mice overexpressing human WT-AURKA or catalytically inactive KD-AURKA, we employed a Cre-lox system. We bred previously described CAG-CAT-Aurka [39] female mice to Zp3-Cre males [40] . These CAG-CAT-Aurka; Zp3-Cre mice are called hereafter WT-Aurka or KD-Aurka, respectively. The CAT sequence contains a polyA signal that terminates transcription. Because the CAT sequence is flanked by two loxP sites, it can be removed by Cre-mediated recombination, and because Cre expression is restricted only to oocytes by Zp3 promotor, WT-or KD-Aurka mice express AURKA only in oocytes. Cdc25b-deficient oocytes were obtained from Cdc25b germ line knockout mice [35] .
Mice were genotyped using tail DNA by PCR as previously described [35, 39] . In experiments using WT-and KD-Aurka mice, we used CAG-CATAurka and/or Zp3-Cre mice as controls; these mice have normal WT phenotypes. For experiments with Cdc25b À/À mice, we used as controls WT C57BL/6NCrl because Cdc25b À/À mice are in a C57BL genetic background.
In Vivo Oocyte Maturation
Oocytes were matured in vivo by administering 5 international units (I.U.) of equine chorionic gonadotropin (eCG) intraperitoneally (i.p.) (Intervet) and 44 h later by 5.I.U. human chorionic gonadotropin (hCG) i.p. (Intervet) to initiate resumption of meiosis. Cumulus cell-enclosed oocytes were isolated in M2 medium (M7167; Sigma Aldrich) at different times after hCG administration; GVBD occurs 3-4 h, MI 7 h, and MII 12 h post-hCG administration. GV-stage oocytes (t ¼ 0) were isolated from eCG-primed mice. GV-intact oocytes, and oocytes that had undergone GVBD or reached MI were isolated from ovaries, whereas MII-ovulated eggs were recovered from the ampullae of the oviduct. Cumulus cells of oocytes recovered from ovaries were removed mechanically, and expanded cumulus cells surrounding MII eggs were removed by hyaluronidase (H4272; Sigma Aldrich) treatment. The use of animals for these experiments was approved by the Animal Care and Use Committee of the Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic.
Oocytes Microinjection and In Vitro Culture
Oocytes were isolated from eCG-primed mice into M2 medium supplemented with 0.1 mM IBMX (I5879; Sigma Aldrich). Cdc25b À/À oocytes were microinjected with Gfp-Aurka cRNA in IBMX-supplemented medium. Two hours later IBMX was washed-out, and the oocytes were cultured in control M16 medium (M7292; Sigma Aldrich) for 4 or 7 h. Production and microinjection of cRNA was performed as described previously [16] .
Quantitative Immunofluorescence Confocal Microscopy
After briefly washing oocytes in PBS, the cells were fixed in 3.7% paraformaldehyde diluted in PBS for 60 min at room temperature; the zona pellucida was not removed. We decided not to remove the zona pellucida for technical reasons: removing the zona pellucida either enzymatically (pronase) or chemically (Tyrode acidic solution) shortly after oocyte isolation and cumulus cells removal produced a strong immunostaining artifact on the oocyte's surface, and such was not case when oocytes were cultured in vitro after isolation. After washing in PBS (3 3 20 min), oocytes were permeabilized with 0.5% Triton X-100 in PBS for 30 min at room temperature and incubated with heat-inactivated 2% normal goat serum in PBS containing 0.2% bovine serum albumin (BSA) for 2 h at room temperature. The oocytes were then incubated overnight at 48C with primary antibodies diluted in PBS/0.2% BSA. After washing the oocytes in PBS (3 3 20 min), the cells were incubated for 60 min at room temperature with the secondary antibodies conjugated with fluorescein isothiocyanate or Texas Red (15 ng/ml). The specificity of the immunostaining was established by omitting the primary antibodies or using another species-specific secondary antibody conjugated to fluorescein. DNA staining was done with 4 0 6-diamidino-2-phenylindole. AURKA phosphorylated on T288 was detected with a rabbit polyclonal antibody (NB100-2371; Novus Biological) at a 1:200 dilution, acetylated atubulin with a mouse monoclonal antibody (T7451; Sigma) at a 1:1000 dilution; c-tubulin with a rabbit polyclonal antibody (620901; Biolegend) at a 1:200 dilution, and pericentrin with a mouse monoclonal antibody (611815; BD Biosciences) at a 1:50 dilution. After a final wash in PBS/BSA, the oocytes were mounted in SOLC ET AL.
Mowiol (Merck, 475904) between a slide and cover glass using a spacer to preserve the three-dimensional (3D) structure of the oocytes.
Oocytes were scanned using either a Leica TCS SP2 or Leica TCS SP5 laser scanning confocal microscope. The same power setting was used, and the signal was not saturated. To avoid spectral overlap, a sequential scan was applied in the 12-bit image depth with a 1024 3 1024 or 512 3 512 pixel image resolution. Three-dimensional scanning was performed using 1-lm optical sections through the oocyte volume.
Image Analysis
For pT288 AURKA MTOC-associated signal quantification (see Fig. 1 ), MTOC(s) mask (selection) was created by intensity thresholding of the pericentrin channel and the immunofluorescent intensity measurement was redirected to the pT288 AURKA channel. The same approach was used for quantifying MTOC-associated c-tubulin. Image analysis was done using FiJi, an ImageJ distribution (http://fiji.sc).
FIG. 1. Activation of AURKA during resumption of meiosis induced by hCG in 0-4 h intervals.
A) The time course of the AURKA activating T288 phosphorylation on MTOC and in the cytoplasm. At 0-, 1-, and 2-h intervals, pericentrin (MTOC marker) and pT288 AURKA are shown in a single confocal section through the MTOC whereas at the 3-and 4-h intervals. the pictures represent maximum projections of 9-11 and 12-19 sections, respectively, to cover MTOC multiplication. DNA is always presented as a maximum projection. Note that pericentrin staining also nonspecifically detected the zona pellucida and precluded using a maximum projection of the entire stack. Entire stacks are available in Supplemental Movie S1. Original magnification 363, zoom 33. B) Quantification of AURKA phosphorylation. Data are means with 95% confidence intervals in arbitrary units.
AURORA KINASE A AND MTOC
To measure the total MTOC volume (see Figs. 4B and 6C), the c-tubulin 12-bit channel was converted by intensity thresholding into the binary channel, individual MTOCs were identified with a 3D object counter, and the MTOC volume was measured. For spindle length measurement (see Fig. 6B ), x, y, z coordinates of spindle poles stained by c-tubulin were stored and the spindle length was calculated as the distance between spindle poles using the Pythagorean theorem. The spindle volume (see Fig. 6B ) was measured from the intensity threshold binary channel of a-tubulin, where spindles were again detected by 3D object counter and where spindle volume was measured using a 3D ROI manager plug-in [41] .
RT-PCR and Western Blot
RT-PCR was done using FastLane Cell SYBR Green Kit (216213; Qiagen) when single oocytes were used directly as substrate for single-step RT-PCR without mRNA purification. To detect human WT or KD-Aurka mRNAs as a product of Aurka transgenes, we designed primers that specifically detected human but not mouse Aurka mRNA. These primers do not discriminate between WT-and KD-Aurka mRNAs. The primers sequences are: TTC CTT GTC AGA ATC CAT TAC and ATG AGG TAC ACT GGT TGC.
For immunoblot detection of overexpressed WT or KD-AURKA, 20 oocytes per sample were used. The antibody was a rabbit polyclonal antibody (3092; Cell Signaling) diluted 1:500 in 5% milk.
Statistics
NCSS2007 software was used (NCSS). Differences in imunofluorescence intensities were evaluated using the Student t-test or its variant Aspin-Welch in the case of unequal variance. When a nonnormal distribution was observed, we used the Mann-Whitney test for differences in the medians. Differences in meiotic maturation progression (GV, GVBD, MII) and differences in the amount of MTOCs between groups were tested by chi-square.
RESULTS
Activation of AURKA in Oocytes Occurs Shortly after hCG Administration and Precedes Resumption of Meiosis
We have shown previously that AURKA activation occurs within 20 min after initiation of maturation in vitro [16] . Because of the differences in spindle morphology when oocytes are matured either in vitro or in vivo [42] , coupled with the role of AURKA in increase in MTOC number, we closely monitored the temporal-spatial time course of AURKA activation during maturation in vivo using quantitative confocal microscopy to detect pT288 AURKA, which serves as a proxy for AURKA activation; the functional relationship between T288 autophosphorylation in the activation loop and kinase activity is well established [43, 44] .
The results of these experiments demonstrated that significant activation of AURKA on MTOCs occurred within 1 h of initiation of maturation and full activation was achieved by 2 h, after which it remained essentially constant ( Fig. 1 ; see also Supplemental Movie S1) [all the Supplemental Data are available online at www.biolreprod.org]. After GVBD, when MTOC multiplication occurred, active AURKA was localized on all the MTOCs. The increase in AURKA activation was apparently restricted to MTOCs because no significant changes in the amount of phosphorylated AURKA were detected in the cytoplasm (Fig. 1B) . In somatic cells, AURKA is implicated as a positive regulator of CDC25B during normal mitotic entry [9] and is essential for G2 checkpoint recovery [10] . The latter situation is very similar in many aspects to resumption of meiosis in oocytes [18] . Because CDC25B is essential for resumption of meiosis [35] , and given the very early activation of AURKA at the onset of initiating maturation and the aforementioned similarity, we tested whether AURKA regulates CDC25B. We found that overexpressing AURKA by microinjecting a cRNA encoding AURKA did not induce resumption of meiosis when maturation was inhibited by including the PDE3A inhibitor, milrinone, in the medium for 18 h [16] . Because meiotic arrest is the result of a highly complex pathway that involves not only cAMP but cGMP as well [45, 46] , this failure may not reflect the role of AURKA in a more physiological context. We, therefore, took an approach that examined the effect of overexpressing AURKA in oocytes within follicles.
We employed a previously published transgenic mouse that carries human WT-or KD-Aurka transgenes under the control of a constitutive CAG promoter [39] . The transgenes are only transcribed after Cre-mediated excision of the floxed CAT inhibitory sequence. Breeding these mice with Zp3-Cre mice allowed us to overexpress WT-or KD-AURKA only in oocytes. Both transgenes were expressed, with higher amounts of KD-AURKA accumulating when compared to WT-AURKA (Fig. 2 , see also Supplemental Movie S2). The amount of WT-AURKA was ;10 times greater than endogenous AURKA because only 20 WT-AURKA oocytes were required to detect a signal following immunoblotting, whereas 200 oocytes were required to detect endogenous AURKRA (data not shown and [16] ). In addition, MTOCs in WT-AURKA oocytes were already associated with activated AURKA (Fig. 2C) , demonstrating that WT-AURKA overexpression lead to the premature AURKA activation.
We next analyzed whether WT-AURKA overexpression induces resumption of meiosis of oocytes enclosed in preovulatory antral follicles. We isolated oocytes from eCGstimulated and -unstimulated mice and found that all the oocytes from the control and WT-and KD-AURKA groups had an intact nucleus, suggesting maintenance of prophase I arrest despite increased AURKA activity in WT-AURKA oocytes. In addition, the kinetics of meiotic resumption (Fig.  3A) and meiotic maturation to metaphase II (Fig. 3B) after hCG administration were unaffected by either WT-or KD-AURKA overexpression. Metaphase II eggs were also able to support normal embryonic development as evidenced by breeding trials conducted over a period of 3-6 mo (Fig. 3C) . We did find, however, that in older mice (7-12 mo), KD-AURKA overexpression led to infertility for unknown reasons. Taken together, these data strongly suggest that activation of AURKA in prophase I arrested oocytes does not trigger resumption of meiosis.
Premature AURKA Activation Leads to the Premature Increase in MTOCs Number
Mouse oocytes, which lack centrosome-containing centrioles [47, 48] , have one to three MTOCs that contain both pericentrin [49] and c-tubulin [50] ; although some authors term MTOCs in oocytes as centrosomes [51] , we use in this report only the term MTOC because a typical centrosome contains centrioles [52] . In addition, MTs form an interphaselike dense network in germinal vesicle (GV)-intact oocytes that are arrested in prophase I, but following initiation of meiotic maturation and prior to GVBD, the number of MTOCs increases and the MT dense network diminishes [53, 54] . Following GVBD, MTOCs congress in the vicinity of the condensed chromosomes and nucleate MTs to form a ball-like structure with MTOCs decorating the surface [54] . The increase in MTOC number and total MTOC volume during resumption of meiosis [53, 54] can be viewed as analogous to centrosome maturation and separation in somatic cells, with both process requiring AURKA activity [14, 52, 55] . A bipolar meiotic spindle forms by the progressive clustering of multiple MTOCs ejected from the MT balls. MTOC clustering, also termed sorting, is governed by hepatoma up-regulated protein (HURP) that is loaded on interpolar MTs in the vicinity of chromosomes via kinesin-5 activity. By promoting MT stability in the spindle's central domain, HURP allows efficient MTOC sorting into distinct poles [56] .
A previous study reported increase in MTOC number, probably due to de novo formation, occurs prior to GVBD when oocytes are matured in vitro [54] . We have shown that overexpression of AURKA induces an increase in MTOC number in prophase I-arrested oocytes as well as later during in vitro meiotic maturation, resulting in formation of defective multipolar spindles and arrest in meiosis I [16] . The observed normal meiotic progression to and arrest at metaphase II in WT-AURKA oocytes matured in vivo, coupled with the normal fertility of the female mice, appears not consistent with the aforementioned in vitro observations.
To gain better insight into the source of these differences we quantified the number of MTOCs during the course of maturation in vivo; we define an increase in MTOC number to have occur when .3 MTOCs are detected. Oocytes arrested within follicles have one to three cytoplasmic MTOC(s). Three to four hours after hCG stimulation to induce maturation, oocytes with a GV still contained one to three MTOC(s) whereas an increase in MTOC number occurred in those that underwent GVBD (Fig. 4, A and B ; see also Supplemental Movies S3-S5). When AURKA activation was accelerated using WT-AURKA oocytes, an increase in MTOC number was already observed in GV-intact oocytes at t ¼ 0 (Fig. 4, A and  B) . This increase, however, was transient because oocytes that were still at the GV-stage 3 h post-hCG only had one to three MTOCs, whereas an increase in MTOC number had occurred in both control and WT-AURKA oocytes during the same time interval in oocytes after GVBD. The transient and premature increase in MTOC number required AURKA kinase activity because KD-AURKA oocytes have the same kinetics of increase in the number of MTOCs as controls. The increase in MTOC number in WT-AURKA GV-intact oocytes at t ¼ 0 was associated with an increase of total MTOC volume (Fig.  4C) , suggesting that this increase was not due to fragmentation of preexisting MTOC(s). The small increase in the total MTOC-associated c-tubulin in WT-AURKA oocytes and decrease in KD-AURKA oocytes were not significant. The significant differences in the amount of c-tubulin between WTand KD-AURKA oocytes (Fig. 4C) , however, implied that AURKA activity positively regulates the amount of c-tubulin in MTOCs and that KD-AURKA exhibits in oocytes a dominant negative effect. Although c-tubulin slightly increased in WT-AURKA oocytes, this increase did not fully compensate for the increase in MTOC number and total volume leading to a decline in c-tubulin intensity on MTOC in WT-AURKA oocytes.
Full Activation of AURKA Essential for Increase in MTOCs Number Depends on CDC25B-CDK1 Activity
The results described above strongly implicate AURKA in an increase in MTOC number and raise the question of the role of CDK1 in this process, that is, whether it is CDK1 dependent or independent. Interestingly, in somatic cells, CDK1-independent activation of AURKA on centrosomes drives centrosome separation [13] . Accordingly, we measured T288 AURKA phosphorylation after hCG administration in oocytes derived from Cdc25b À/À mice; CDC25B is essential for CDK1 activation and resumption of meiosis [35] . At 4 and 7 h posthCG administration, AURKA was activated on MTOCs and MTOC multiplication had occurred in WT oocytes. In contrast, AURKA was only partially activated, and an increase in MTOC number did not occur in Cdc25b À/À oocytes (Fig. 5 , A and B; see also Supplemental Movies S6 and S7), that is, CDC25B-dependent CDK1 activation was essential for complete AURKA activation.
The remaining question was whether the increase in MTOC number deficiency was due to partial AURKA activation in Cdc25b À/À oocytes. Because AURKA overexpression induced MTOC multiplication in WT oocytes in vitro [16] , we microinjected a Gfp-Aurka cRNA into the Cdc25b À/À oocytes matured in vitro. We found that GFP-AURKA restored the increase in MTOC number in these oocytes, although they remained arrested in prophase I because of the absence of CDC25B (Fig. 5C ).
AURKA Influences Spindle Length and Regulates, Independent of Its Kinase Activity, MTOC-Associated cTubulin
We previously demonstrated that overexpressing AURKA during in vitro maturation leads to an elongated metaphase I spindle or multipolar spindle formation that in each case is accompanied by metaphase I arrest [16] . In contrast, results from the in vivo maturation studies of WT-AURKA oocytes show normal maturation with arrest at metaphase II and normal embryonic development after fertilization. Therefore, we ascertained the effect of WT-and KD-AURKA on spindle morphology of metaphase I oocytes. WT-AURKA oocytes exhibited a normal bipolar spindle that was elongated (Fig. 6, A and B) . This elongation depended on protein kinase activity because spindle length was unaffected in KD-AURKA oocytes (Fig. 6, A and B) . The elongated WT-AURKA spindles had the same volume as control (Fig. 6B) , documenting that elongation was not a result of increased spindle volume. Surprisingly, KD-AURKA spindles were slightly but significantly smaller in volume than controls, suggesting that KD-AURKA exhibited a dominant negative effect similar to that observed for the amount of MTOC-associated c-tubulin in prophase I arrested oocytes (Fig. 4C) . c-Tubulin staining revealed that metaphase I oocytes had a normal number of MTOCs focused on spindle poles as well as in the cytoplasm regardless of AURKA status (Fig. 6, A  and C) . However, total MTOC volume (Fig. 6C) , total amount of MTOC associated c-tubulin, and c-tubulin density on MTOCs were higher both in WT-AURKA and KD-AURKA oocytes (Fig. 6, A and C) . This finding suggests that AURKA regulates c-tubulin turnover independent of its protein kinase activity.
DISCUSSION
The LH surge is the primary trigger that initiates ovulation, cumulus cell expansion, and meiotic maturation by its binding to LH receptors located on follicle cells. Luteinizing hormone's ability to initiate oocyte maturation is indirect and occurs by driving expression of EGF-like peptides in mural granulosa cells that in turn leads to signaling events in cumulus cells that result not only in cumulus cell expansion but also meiosis resumption in the oocyte [57, 58] . Our finding that AURKA activation occurs as early as 1 h after hCG stimulation (Fig. 1) is interesting given that increased mRNA expression of the EGF-like peptides amphiregulin and epiregulin is also observed in mural granulosa cells within an hour [58] . The timing of these events suggests that the initial activation of AURKA is mediated by shedding of a preexisting pool of EGF-like ligands [57] . Alternatively, there may exist an EGFlike independent signaling mechanism that triggers AURKA activation in oocytes.
AURKA-dependent CDC25B phosphorylation facilitates mitotic entry in cancerous somatic cells [9] , although AURKA is not absolutely essential for normal mitotic entry [6, 12, 13] . On the other hand both AURKA [10, 15] and CDC25B [59, 60] are crucial for G2 checkpoint recovery following prolonged DNA-damage induced G2-arrest that is very similar in many aspects to resumption of meiosis in oocytes after long prophase I arrest [18] . CDC25B is essential for resumption of meiosis in mouse oocytes [35] . Microinjection of a constitutively active AURKA into Xenopus oocytes induces hormone-independent resumption of meiosis [22] and forces activation of AURKA in porcine oocytes that facilitates resumption of meiosis by increasing CCNB synthesis [23] . Although these results implicate AURKA as a triggering protein kinase for resumption of meiosis, we find that overexpressing WT-AURKA in oocytes neither triggers meiosis resumption nor accelerates the time to GVBD (Fig. 3A) in oocytes present in preovulatory antral follicles. This finding is consistent with the current view that prophase I arrest depends mainly on PKA-mediated CDC25B inhibition in which resumption of meiosis is linked to increased CDC25B activity as a consequence of decreased PKA activity; PKA catalyzes an inhibitory phosphorylation of CDC25B [36, 61, 62] . On the other hand, both RNAi-mediated [16] or pharmacological AURKA [18] inhibition delay resumption of meiosis, suggesting that although AURKA is involved in amplification of signaling leading to meiosis resumption, other molecules are rate-limiting because AURKA overexpression does not accelerate GVBD.
During hCG-induced resumption of meiosis, the increase in MTOC number occurs shortly after GVBD (Fig. 4) , which differs from in vitro maturation in which an increase in MTOC number occurs before GVBD [53] ; overexpression of WT-AURKA induces premature increase in MTOC number in prophase I-arrested oocytes. Surprisingly, this induced increase that occurs during maturation in vivo is transient and is not observed ;3 h after hCG administration, that is, very shortly before GVBD. Thus, oocytes may have a mechanism that tightly controls the number of MTOCs before GVBD. This mechanism may be similar to centrosome clustering that occurs in many cancer cells but also during physiological hepatocyte polyploidization [63] . Alternatively, prematurely formed new MTOCs may not be fully mature and therefore unstable. If the second possibility is true, it raises the question why prematurely multiplied MTOCs are unstable in oocytes shortly before GVBD but not in oocytes arrested in prophase I? One explanation is that MTOC instability is a consequence of a decline in c-tubulin density in WT-AURKA prophase Iarrested oocytes (Fig. 4C) . Alternatively, the concentration of an AURKA activator such as TPX2, may be limiting, because TPX2 increases progressively during meiotic maturation, reaching its highest levels only at metaphase I and II [21] .
Another contributing factor to MTOC instability could be dephosphorylation of AURKA substrates important for MTOC development following hCG administration and prior to GVBD. One possible candidate is TACC3, which is phosphorylated during meiotic maturation [21] . We observed in preliminary studies, however, that the p-TACC3 signal is already associated with MOTCs in prophase I-arrested oocytes and transiently decreases between 1 and 2 h post-hCG administration and then increased from 3-4 h (data not shown). Thus, phosphorylation of TACC3 does not correlate with AURKA phosphorylation, that is, it is likely that other protein kinases (and phosphatases) are involved. Moreover, in prophase I-arrested oocytes, the amount of p-TACC3 associated with MTOC is very high in WT-AURKA oocytes when compared to control oocytes (data not shown).
In metaphase I oocytes AURKA overexpression induces increase both in total MTOC volume and the total amount of MTOC associated c-tubulin independent of its activity although the number of MTOC is the same in control WTand KD-AURKA oocytes (Fig. 6) . These data document a cell cycle stage different role for AURKA in MTOC metabolism. In prophase I, AURKA activity increases MTOC number, total MTOC volume, and amount of c-tubulin in MTOCs-a process that can be viewed as analogous to centrosome maturation and separation in somatic cells [14, 52, 55] . However, later in meiosis in metaphase I, AURKA, independent of its protein kinase activity, positively regulates MTOC volume and the amount of MTOC-associated c-tubulin, but has little effect on total MTOC number. In somatic cells, AURKA associates with centrosomin and localizes to spindle poles that target c-tubulin to centrosomes [1] . In Caenorhabditis elegans early embryos, AURKA independent of its protein-kinase activity regulates assembly of c-tubulin-independent microtubules [64] .
Our data showing that WT-AURKA overexpression triggers a premature increase in MTOC number without triggering resumption of meiosis is consistent with an uncoupling of the resumption of meiosis (in term of GVBD and chromosome condensation) from the increase in MTOC number. For oocytes present in follicles, the two are coupled during in vivo maturation, possibly by CDK1 activating AURKA (see below). In mammalian somatic cells, AURKA is activated on centrosomes in G2 independent of CDK1 activity and promotes centrosome separation. Later in mitosis, AURKA activity depends on CDK1 [13] , whose activation during resumption of meiosis in mouse oocytes requires CDC25B [35] . We find that AURKA is partially activated on MTOCs in Cdc25b À/À oocytes. MTOC multiplication, however, is a CDK1-dependent process and requires full AURKA activation (Fig. 5, A and B) . CDK1 activity is involved in increase in MTOC number indirectly through full AURKA activation because microinjection of a Gfp-Aurka cRNA into the Cdc25b À/À oocytes restores increase in MTOC number (Fig.  5C ). These data suggest that the first wave of AURKA activation is CDK1 independent, but full AURKA activation, essential for increase in MTOCs number, is CDK1 dependent. In contrast, in somatic cells, the initial G2-associated CDK1-independent AURKA activation drives centrosome separation [13] .
WT-AURKA, but not KD-AURKA, oocytes exhibit longer spindle than controls (Fig. 6, A and B ; see also Supplemental Movie S8); chromosome alignment is not affected. Of note is that in Xenopus egg extracts, depletion of either AURKA (Eg2) or its substrate TACC3 (Maskin) leads to formation of shorter spindles [65] . We previously observed spindle elongation or spindle disorganization [16] following GFP-AURKA overexpression and maturation in vitro. There are several explanations why in vivo WT-AURKA overexpression does not disorganize spindles. For example, the extent of overexpression in the two models may differ; in the in vitro model, low levels of AURKA expression permitted normal spindle formation, whereas high levels resulted in disorganized spindles. Alternatively, as described above, the concentration of AURKA activator such TPX2 may be rate limiting. Last, because transgenic overexpression occurs over the course of oocyte growth, that is, weeks (and is not short-term as it is in the in vitro model, i.e., hours), the higher amount of AURKA activity may elicit a compensatory response, for example, increasing phosphatase activity or decreasing the amount of AURKA protein. Consistent with the latter proposal is the lower amount of WT-AURKA than KD-AURKA, although their transcript abundance is quite similar (Fig. 2) . Note that different spindle lengths are observed in oocytes from different strains [66] , and therefore AURKA could contribute to these differences.
In conclusion, we show that during in vivo meiotic maturation AURKA is activated as early as 1 h post-hCG administration and the initial AURKA activation does not require CDK1 activity. A physiological increase in MTOC number occurs in vivo shortly after GVBD, and CDC25B-CDK1 is required for full AURKA activation that drives MTOC increase. Later in meiosis I, AURKA activity positively regulates spindle length, and in a protein kinase-independent manner, AURKA positively regulates the amount of MTOC associated c-tubulin. Although AURKA was proposed in Xenopus oocytes as a trigger protein kinase for resumption of meiosis, our finding suggest such is not the case, at least in mouse, because AURKA overexpression using a transgenic model does not induce resumption of meiosis of oocytes within preovulatory antral follicles in the absence of an hCG stimulus.
